TWIST1 and ovarian carcinoma: The siRNA targeting TWIST (siTWIST) was delivered to cisplatin-resistant ovarian cancer cells using PAMAM dendrimers and mesoporous silica nanoparticles (A2780R) (Roberts et al., 2017).